Kappos L - Search Results

1

Efficacy and Safety of Fingolimod in an Unselected Patient Population.

Rasenack M, Rychen J, Andelova M, Naegelin Y, Stippich C, Kappos L, Lindberg RL, Sprenger T, Derfuss T. Rasenack M, et al. Among authors: kappos l. PLoS One. 2016 Jan 6;11(1):e0146190. doi: 10.1371/journal.pone.0146190. eCollection 2016. PLoS One. 2016. PMID: 26734938 Free PMC article.

2

The expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in lesions and normal appearing white matter of multiple sclerosis.

Lindberg RL, De Groot CJ, Montagne L, Freitag P, van der Valk P, Kappos L, Leppert D. Lindberg RL, et al. Among authors: kappos l. Brain. 2001 Sep;124(Pt 9):1743-53. doi: 10.1093/brain/124.9.1743. Brain. 2001. PMID: 11522577

3

Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis.

Leppert D, Lindberg RL, Kappos L, Leib SL. Leppert D, et al. Among authors: kappos l. Brain Res Brain Res Rev. 2001 Oct;36(2-3):249-57. doi: 10.1016/s0165-0173(01)00101-1. Brain Res Brain Res Rev. 2001. PMID: 11690622 Review.

4

Neutralizing antibodies against IFN-beta in multiple sclerosis: antagonization of IFN-beta mediated suppression of MMPs.

Gilli F, Bertolotto A, Sala A, Hoffmann F, Capobianco M, Malucchi S, Glass T, Kappos L, Lindberg RL, Leppert D. Gilli F, et al. Among authors: kappos l. Brain. 2004 Feb;127(Pt 2):259-68. doi: 10.1093/brain/awh028. Epub 2003 Nov 7. Brain. 2004. PMID: 14607790

5

Multiple sclerosis as a generalized CNS disease--comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS.

Lindberg RL, De Groot CJ, Certa U, Ravid R, Hoffmann F, Kappos L, Leppert D. Lindberg RL, et al. Among authors: kappos l. J Neuroimmunol. 2004 Jul;152(1-2):154-67. doi: 10.1016/j.jneuroim.2004.03.011. J Neuroimmunol. 2004. PMID: 15223248

6

Genomics and proteomics: role in the management of multiple sclerosis.

Kappos L, Achtnichts L, Dahlke F, Kuhle J, Naegelin Y, Sandbrink R, Lindberg RL. Kappos L, et al. J Neurol. 2005 Sep;252 Suppl 3:iii21-iii27. doi: 10.1007/s00415-005-2013-3. J Neurol. 2005. PMID: 16170496 Review.

7

Gelatinase B [matrix metalloproteinase (MMP)-9] and collagenases (MMP-8/-13) are upregulated in cerebrospinal fluid during aseptic and bacterial meningitis in children.

Lindberg RL, Sorsa T, Tervahartiala T, Hoffmann F, Mellanen L, Kappos L, Schaad UB, Leib SL, Leppert D. Lindberg RL, et al. Among authors: kappos l. Neuropathol Appl Neurobiol. 2006 Jun;32(3):304-17. doi: 10.1111/j.1365-2990.2006.00729.x. Neuropathol Appl Neurobiol. 2006. PMID: 16640649

8

Oral fingolimod (FTY720) for relapsing multiple sclerosis.

Kappos L, Antel J, Comi G, Montalban X, O'Connor P, Polman CH, Haas T, Korn AA, Karlsson G, Radue EW; FTY720 D2201 Study Group. Kappos L, et al. N Engl J Med. 2006 Sep 14;355(11):1124-40. doi: 10.1056/NEJMoa052643. N Engl J Med. 2006. PMID: 16971719 Free article. Clinical Trial.

9

Transcriptional profiling of multiple sclerosis: towards improved diagnosis and treatment.

Lindberg RL, Kappos L. Lindberg RL, et al. Among authors: kappos l. Expert Rev Mol Diagn. 2006 Nov;6(6):843-55. doi: 10.1586/14737159.6.6.843. Expert Rev Mol Diagn. 2006. PMID: 17140371 Review.

10

Lack of association between antimyelin antibodies and progression to multiple sclerosis.

Kuhle J, Pohl C, Mehling M, Edan G, Freedman MS, Hartung HP, Polman CH, Miller DH, Montalban X, Barkhof F, Bauer L, Dahms S, Lindberg R, Kappos L, Sandbrink R. Kuhle J, et al. Among authors: kappos l. N Engl J Med. 2007 Jan 25;356(4):371-8. doi: 10.1056/NEJMoa063602. N Engl J Med. 2007. PMID: 17251533 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

795 results

Search Page